Stem Cells and Cancer Stem Cells in Mouse Mammary Glands
(MG stem)
Start date: May 25, 2009,
End date: May 24, 2013
PROJECT
FINISHED
It is thought that, although cancer stem cells are a small minority in the tumor cell population, they can escape the toxicity of drugs used for treatment, as they are relatively quiescent, i.e. chemotherapy can lead effectively to remission, but not frequently to a cure. An important question that cannot be answered at present and should certainly be addressed is whether a therapeutic window can be identified from the differences between normal cells, including normal stem cells, and cancer stem cells. The proposed work is a first step towards addressing this crucial question by examining in the context of mouse models of mammary tumorigenesis the relationship between putative normal and cancer stem cells and comparing their expression profiles with a long-term goal of eventually identifying advantageous drug-targets for therapeutic intervention to treat breast cancer. The use of stemness signatures for treatment purposes may find additional applications in the cases of cancers at other anatomical sites.
Get Access to the 1st Network for European Cooperation
Log In
or
Create an account
to see this content
Coordinator
- Dimitris Raptis
- SORANOU EFESIOU 4 11527 ATHINA (Greece)
Details
- 100% € 100 000,00
-
FP7-PEOPLE
- Project on CORDIS Platform